ArticlePharmaceuticals (Basel, Switzerland)2021

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma.

Koen G A M Hussaarts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.